Renal injury can sometimes be induced by drugs. Some examples of renal damage-inducing drugs include some widespread treatments, such as ß-Lactam antibiotics, bisphosphonates, non-steroidal anti-inflammatory drugs, diuretics, aminoglycoside antibiotics, antineoplastic agents and radiocontrast agents.
Since 2008, both the FDA and the EMEA indicated that additional tests may be necessary to assess new drug safety and prevent from renal toxicity. Though these recommendations are voluntary, many pharmaceutical companies have started gathering data on nephrotoxicity biomarkers.
Breaking news for cancer researchers! We are pleased to have recently added innovative cancer Arrays to our product offer. You might tell me that there are a lot of new cancer arrays every year and it’s not really necessary to write a post about it… but read on and I’m sure you’ll share my enthusiasm!
Good news for the interferon domain this week with the launch of a new kit: the Verikine Human Interferon Gamma Receptor 1 (IFNGR1) ELISA Kit. This immunoassay provides researchers with a high quality product and excellent data reproducibility for this area.